Contineum Therapeutics stock falls on phase 2 trial miss
Original source: https://www.investing.com/news/stock-market-news/contineum-therapeutics-stock-falls-on-phase-2-trial-miss-93CH-4900355
Read More »Why is Monte Rosa Therapeutics stock plunging today?
Original source: https://www.investing.com/news/stock-market-news/why-is-monte-rosa-therapeutics-stock-plunging-today-93CH-4827990
Read More »Why is Replimune stock plunging today?
Original source: https://www.investing.com/news/stock-market-news/why-is-replimune-stock-plunging-today-93CH-4816666
Read More »Shattuck Labs stock jumps 17% on Phase 1 trial results
Original source: https://www.investing.com/news/stock-market-news/shattuck-labs-stock-jumps-17-on-phase-1-trial-results-93CH-4730647
Read More »Qiagen raises 2025 earnings outlook, preliminary Q1 sales ahead of estimates
Original source: https://www.investing.com/news/stock-market-news/qiagen-raises-2025-earnings-outlook-preliminary-q1-sales-ahead-of-estimates-93CH-3969552
Read More »Edgewise Therapeutics CSO sells over $2 million in company stock
Original source: https://www.investing.com/news/stock-market-news/edgewise-therapeutics-cso-sells-over-2-million-in-company-stock-93CH-3631029
Read More »MBX Biosciences insider buys $8 million in company stock
Original source: https://www.investing.com/news/stock-market-news/mbx-biosciences-insider-buys-8-million-in-company-stock-93CH-3620493
Read More »MBX Biosciences insider purchases $8 million in company stock
Original source: https://www.investing.com/news/stock-market-news/mbx-biosciences-insider-purchases-8-million-in-company-stock-93CH-3620494
Read More »Moderna’s updated COVID vaccine effective against ‘Eris’ variant in humans
Original source: https://www.investing.com/news/stock-market-news/modernas-updated-covid-vaccine-effective-against-eris-variant-in-humans-3156925
Read More »